Literature DB >> 18653598

Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide.

J Jonisch1, J C Lai, V A Deramo, A J Flug, D M Fastenberg.   

Abstract

AIM: To report an increased incidence of sterile endophthalmitis following intravitreal injection of preserved triamcinolone acetonide (IVTA) from 1 May to 31 July 2006.
METHODS: Charts were reviewed for all patients who underwent IVTA injections between 1 January 2005 and 31 July 2006 at the offices of a referral vitreo-retinal practice. Patients were included if they presented post-IVTA with a clinical picture consistent with endophthalmitis.
RESULTS: Between 1 January 2005 and 31 July 2006, 554 eyes underwent IVTA. Eleven eyes (1.9%) developed an endophthalmitis. All eleven eyes underwent vitreous tap and intravitreal injection of antibiotics. All cultures and gram stains were negative for bacterial or fungal organisms. From 1 May to 31 July 2006, 97 eyes underwent IVTA. Nine eyes (9.3%) developed sterile endophthalmitis. This represented a statistically significant (p<0.0001) clustering of cases. Triamcinolone acetonide phials from affected lot numbers were analysed and were all found to be negative for bacterial endotoxin (<0.05 EU/ml).
CONCLUSION: Over the 19-month period analysed, 11 cases of sterile endophthalmitis occurred following IVTA, and nine of these cases were clustered over a 3-month period. No endotoxin was detected in the phials tested. The aetiology of this increased incidence of sterile endophthalmitis is still unclear.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18653598     DOI: 10.1136/bjo.2007.136069

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Triamcinolone crystal size.

Authors:  Mark E Kleinman; Scott J Westhouse; Jayakrishna Ambati; P Andrew Pearson; Lawrence S Halperin
Journal:  Ophthalmology       Date:  2010-08       Impact factor: 12.079

2.  Associated factors and treatment outcome of presumed noninfectious endophthalmitis occurring after intravitreal triamcinolone acetonide injection.

Authors:  Seong Joon Ahn; Tae Wan Kim; Jeeyun Ahn; Jang Won Huh; Hyeong Gon Yu; Hum Chung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-22       Impact factor: 3.117

3.  Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France.

Authors:  Florian Baudin; Eric Benzenine; Anne-Sophie Mariet; Alain M Bron; Vincent Daien; Jean François Korobelnik; Catherine Quantin; Catherine Creuzot-Garcher
Journal:  JAMA Ophthalmol       Date:  2018-12-01       Impact factor: 7.389

Review 4.  Sterile endophthalmitis after intravitreal injections.

Authors:  Joaquín Marticorena; Vito Romano; Francisco Gómez-Ulla
Journal:  Mediators Inflamm       Date:  2012-08-29       Impact factor: 4.711

5.  Sterile endophthalmitis rates and particle size analyses of different formulations of triamcinolone acetonide.

Authors:  David G Dodwell; Darrel A Krimmel; Christopher M de Fiebre
Journal:  Clin Ophthalmol       Date:  2015-06-09

6.  Incidence and Determinants of Endophthalmitis within 6 Months of Surgeries over a 2-Year Period at King Khaled Eye Specialist Hospital, Saudi Arabia: A Review.

Authors:  Rajiv Khandekar; Saeed Al-Motowa; Hind M Alkatan; Mohammed Karaoui; Anne Ortiz
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

7.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.